ArticleParkinsonism & related disorders2025
Does exercise demonstrate a dose-dependent benefit with cognition in Parkinson's disease?
Article in Parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundExercise confers motor benefits in Parkinson's disease (PD) and may even have disease modifying effects. While the impact of exercise on motor symptoms and quality of life is well-studied in PD, its relationship with cognitive performance warrants further attention.
methodsIn people with PD, self-reported exercise information was quantified using the Rapid Assessment of Physical Activity (RAPA). Cognitive performance was assessed using the symbol digit modalities test (SDMT) and Stroop tests. The association between test performance and intensity of physical exercise, as measured by the RAPA, was assessed using linear regression, adjusting for covariates of age and duration of Parkinson's disease.
results172 participants completed Stroop testing and 181 completed SDMT in both medication "off" and "on" states. Compared with participants reporting no exercise, those with mild activity (RAPA frequency/duration score 2-3) performed better on the SDMT (β = 1.31, p = 0.01) and Stroop color naming (β = 9.19, p = 0.02). Highly active participants (RAPA frequency/duration score 6-7) scored significantly higher than those with moderate activity (RAPA frequency/duration score 4-5) on the SDMT (β = 1.44, p < 0.01) and Stroop color naming (β = 4.66, p = 0.03).
conclusionHigher self-reported physical activity levels were associated with higher cognitive performance in a dose-dependent fashion in both the off-medication and on-medication states. The greatest difference in cognitive performance was seen between those reporting no exercise and those reporting at least some activity, suggesting that even small amounts of physical activity can benefit cognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.